{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:35:56Z","timestamp":1792899356460,"version":"4.5.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["ASSAY and Drug Development Technologies"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">The current work aimed to investigate the therapeutic potential of<\/jats:italic>\n                    Pluchea lanceolata\n                    <jats:italic toggle=\"yes\">(Rasna) in the management of rheumatoid arthritis (RA) using<\/jats:italic>\n                    in silico, in vitro,\n                    <jats:italic toggle=\"yes\">and<\/jats:italic>\n                    in\u00a0vivo\n                    <jats:italic toggle=\"yes\">studies. After administering Rasna (aqueous and ethanolic extracts), physical parameters such as paw volume and arthritic score were found suppressed in rats (in Freund\u2019s complete adjuvant-induced model). Also, radiography and histopathological findings revealed that joint deformities, pannus formation, and tissue swelling of the ankle joint improved when compared with standard and arthritis-induced after 4 weeks. Simultaneously, ELISA results revealed that the serum levels of IL-1\u03b2, IL-6, TNF-\u03b1, C-reactive protein (CRP), and COL2A1 were lowered when compared with the standard group. An<\/jats:italic>\n                    in silico\n                    <jats:italic toggle=\"yes\">study revealed that quercetin, isorhamnetin, and linalool were the potential active phytoconstituents and showed promising binding affinity toward targets such as KDR (VEGFR2), matrix metalloproteinase (MMPs), ALOX5, IL-1\u03b2, IL-6, TNF-\u03b1, CRP, and COL2A1. The biological mechanism of Rasna includes several molecular and cellular functions involving the downregulation of angiogenesis through the vascular endothelial growth factor signaling pathway, the MAPK signaling pathway, PI3K-Akt signaling pathway, and the reduction of cytokines and anti-collagen II antibodies. Rasna inhibits the activation of the abovementioned pathways and mRNA expression of IL-1\u03b2, IL-6, and TNF-\u03b1 in RA. The study suggested the potential use of Rasna in managing arthritis treatment over the conventional therapy in immunocompromised patients.<\/jats:italic>\n                  <\/jats:p>","DOI":"10.1177\/1540658x261472169","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:57:10Z","timestamp":1787137030000},"page":"610-639","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiangiogenic Effect of\n                    <i>Pluchea lanceolata<\/i>\n                    in Adjuvant-Induced Rheumatoid Arthritis in Wistar Rats by Downregulating VEGF Signaling Pathway and Proinflammatory Cytokines"],"prefix":"10.1177","volume":"24","author":[{"given":"Nimesh","family":"Bhardwaj","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Kr.","family":"Dixit","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandasamy","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-088X","authenticated-orcid":false,"given":"Snigdha","family":"Bhardwaj","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Krishna Institute of Engineering &amp; Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12661"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/129873"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.13326"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13103"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.09.027"},{"issue":"7","key":"e_1_3_3_7_1","first-page":"109","article-title":"Therapeutic uses of Rasna (Pluchea lanceolata): A review article","volume":"6","author":"Manisha","year":"2020","unstructured":"6.Manisha, , Naresh KG. Therapeutic uses of Rasna (Pluchea lanceolata): A review article. World J Pharm Med Res 2020;6(7):109\u2013112.","journal-title":"World J Pharm Med Res"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1007-1110"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22071135"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.26452\/ijrps.v11iSPL4.4355"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.22271\/chemi.2020.v8.i2i.8834"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.3329\/bjp.v10i4.23779"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.37212\/jcnos.1117261"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomag.2012.01.002"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2006.07.025"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.967164"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2020.1742732"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/bip.22878"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1037"},{"issue":"1","key":"e_1_3_3_20_1","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Janet P","year":"2020","unstructured":"19.Janet P, , Manuel R-AJ, , Josep S-P, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 2020;48(D1):D845\u2013D855.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"e_1_3_3_21_1","first-page":"D605","article-title":"The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Damian S","year":"2020","unstructured":"20.Damian S, , Gable AL, , Nastou KC, et al. The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 2020;49(D1):D605\u2013D612.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31472-1"},{"issue":"6","key":"e_1_3_3_24_1","first-page":"631","article-title":"Treatment strategies in rheumatoid arthritis","volume":"33","author":"Boey ML","year":"1992","unstructured":"23.Boey ML. Treatment strategies in rheumatoid arthritis. Singapore Med J 1992;33(6):631\u2013632.","journal-title":"Singapore Med J"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-8-199604150-00012"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-4328(87)90032-5"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2427(02)00069-7"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.5.13.1916105"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel237"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108454"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110301"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110517"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600912"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01819-6"}],"container-title":["ASSAY and Drug Development Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1540658X261472169","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1540658X261472169","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1540658X261472169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:17:27Z","timestamp":1792898247000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1540658X261472169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11,1]]}},"alternative-id":["10.1177\/1540658X261472169"],"URL":"https:\/\/doi.org\/10.1177\/1540658x261472169","relation":{},"ISSN":["1540-658X","1557-8127"],"issn-type":[{"value":"1540-658X","type":"print"},{"value":"1557-8127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}